S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

TSHA Taysha Gene Therapies Inc

1.75

0.00 (0.00%)

Pre Market

Last Updated: 03:55:41

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Taysha Gene Therapies Charts.

Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Taysha Gene Therapies Charts.

Taysha Gene Therapies Inc News

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 7 March 2025 (3 days ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 26 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 26 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update
Wednesday 26 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26
Wednesday 19 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 7 February 2025 (1 month ago) • GlobeNewswire Inc.

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 5 February 2025 (1 month ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 7 January 2025 (2 months ago) • Edgar (US Regulatory)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 3 January 2025 (2 months ago) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Friday 13 December 2024 (3 months ago) • Edgar (US Regulatory)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 6 December 2024 (3 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (4 months ago) • Edgar (US Regulatory)

More Taysha Gene Therapies Inc News Articles

Targets Trust Xxiii

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions